John W. Gamble Jr. - 01 May 2026 Form 4 Insider Report for EQUIFAX INC (EFX)

Reporting relationship: EVP, CFO & COO
Issuer ticker: EFX
Reported as of: 01 May 2026
Net transaction value: -$617,890
SEC form: 4
Accepted by SEC: 05 May 2026, 16:09:43 UTC
Prior SEC filing: 27 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/Lisa Stockard as Attorney-in-Fact

Key filing fact

John W. Gamble Jr. filed Form 4 for EQUIFAX INC (EFX) on 05 May 2026.

Key facts

This page summarizes John W. Gamble Jr.'s Form 4 filing for EQUIFAX INC (EFX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 May 2026, 16:09.

Change

Previous filing in this sequence was filed on 27 Feb 2026.
Current net transaction value: -$617,890.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001222712 Primary reporting owner

GAMBLE JOHN W JR

Relationship: EVP, CFO & COO
Address: 1550 PEACHTREE STREET, N.W., ATLANTA
Signature: /s/Lisa Stockard as Attorney-in-Fact
Signature date: 05 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EFX transaction

Common Stock

Sale

Transaction value: $617,890
Shares: -3,500
Change %: -4.5%
Price: $176.54
Shares after: 73,464
Date: 01 May 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/21/2025.

Footnote F2

Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.